These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 38112903)

  • 1. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments.
    Abedizadeh R; Majidi F; Khorasani HR; Abedi H; Sabour D
    Cancer Metastasis Rev; 2024 Jun; 43(2):729-753. PubMed ID: 38112903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Looking back 2018--focused on colorectal cancer].
    Cai J; Wang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):9-16. PubMed ID: 30703787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.
    Zheng Y; Fu Y; Wang PP; Ding ZY
    Dis Markers; 2022; 2022():8270305. PubMed ID: 35211210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune checkpoint inhibitors in the treatment of colorectal cancer: a review of clinical trials].
    Gong XL; Zhao L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):205-213. PubMed ID: 35340169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer.
    Dekker E; Tanis PJ; Vleugels JLA; Kasi PM; Wallace MB
    Lancet; 2019 Oct; 394(10207):1467-1480. PubMed ID: 31631858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The past, present, and future of immunotherapy for colorectal cancer.
    Formslag CR; Zhao L; Heslin AJ; Lewis CC; Miller CW; Bai Q; Wakefield MR; Fang Y
    Med Oncol; 2023 Feb; 40(3):95. PubMed ID: 36786890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment.
    Yao S; Han Y; Yang M; Jin K; Lan H
    Front Immunol; 2023; 14():1292861. PubMed ID: 38077354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy in colorectal cancer treatment: present and future.
    Shi J; Sun Z; Gao Z; Huang D; Hong H; Gu J
    Front Immunol; 2023; 14():1105180. PubMed ID: 37234164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-enabled colorectal cancer therapy.
    Pan Q; Fan X; Xie L; Wu D; Liu R; Gao W; Luo K; He B; Pu Y
    J Control Release; 2023 Oct; 362():548-564. PubMed ID: 37683732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
    Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
    Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for colorectal cancer.
    Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
    World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancer].
    Luna-Pérez P; Reyna Huelga A; Rodríguez Coria DF; Medrano R; González Macouzet J
    Rev Gastroenterol Mex; 1997; 62(3):175-83. PubMed ID: 9480524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and prospect of immunotherapy for colorectal cancer.
    Yang W; Zheng H; Lv W; Zhu Y
    Int J Colorectal Dis; 2023 Nov; 38(1):266. PubMed ID: 37962772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer.
    Bess SN; Greening GJ; Muldoon TJ
    Cytokine Growth Factor Rev; 2019 Oct; 49():1-9. PubMed ID: 31679887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of metastatic competency in colorectal cancer.
    Tauriello DV; Calon A; Lonardo E; Batlle E
    Mol Oncol; 2017 Jan; 11(1):97-119. PubMed ID: 28085225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for microsatellite-instability-high advanced colorectal cancer].
    Ding PR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):199-204. PubMed ID: 35340168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy.
    Picco G; Cattaneo CM; van Vliet EJ; Crisafulli G; Rospo G; Consonni S; Vieira SF; Rodríguez IS; Cancelliere C; Banerjee R; Schipper LJ; Oddo D; Dijkstra KK; Cinatl J; Michaelis M; Yang F; Di Nicolantonio F; Sartore-Bianchi A; Siena S; Arena S; Voest EE; Bardelli A; Garnett MJ;
    Cancer Discov; 2021 Aug; 11(8):1923-1937. PubMed ID: 33837064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status and prospect of immunotherapy in colorectal cancer.
    Shu Y; Zheng S
    Clin Transl Oncol; 2024 Jan; 26(1):39-51. PubMed ID: 37301804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.